Ladenburg Thalmann Financial Services’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,817	Closed	-$79K	–	5677
2019 Q3	$79K	Buy	2,817 +2,156	+326%	+$34.9K	﹤0.01%	3119
2019 Q2	$9K	Buy	661 +313	+90%	+$2.98K	﹤0.01%	4506
2019 Q1	$3K	Buy	+348	New	+$2.83K	﹤0.01%	4888

Ladenburg Thalmann Financial Services's DOVA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 2,817 shares — an estimated $79K sold.

Ladenburg Thalmann Financial Services first reported a position in DOVA in Q1 2019 and held it in 3 quarters. The position peaked at $79K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Ladenburg Thalmann Financial Services reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 2,817 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $79K.
Ladenburg Thalmann Financial Services first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Ladenburg Thalmann Financial Services's Dova Pharmaceuticals, Inc. Common Stock position peaked at $79K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.